Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel

There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC. A computeris...

Full description

Saved in:
Bibliographic Details
Published inEuropean urology Vol. 70; no. 6; pp. 1052 - 1068
Main Authors Seisen, Thomas, Peyronnet, Benoit, Dominguez-Escrig, Jose Luis, Bruins, Harman M., Yuan, Cathy Yuhong, Babjuk, Marko, Böhle, Andreas, Burger, Maximilian, Compérat, Eva M., Cowan, Nigel C., Kaasinen, Eero, Palou, Joan, van Rhijn, Bas W.G., Sylvester, Richard J., Zigeuner, Richard, Shariat, Shahrokh F., Rouprêt, Morgan
Format Journal Article
LanguageEnglish
Published Switzerland Elsevier B.V 01.12.2016
Subjects
Online AccessGet full text
ISSN0302-2838
1873-7560
1873-7560
DOI10.1016/j.eururo.2016.07.014

Cover

Abstract There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC. A computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point. Seven studies compared KSS overall (n=547) versus RNU (n=1376). Information on the comparison of SU (n=586) versus RNU (n=3692), URS (n=162) versus RNU (n=367), and PC (n=66) versus RNU (n=114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS. Our systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias. We reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours. The use of endoscopic surgery for upper tract urothelial carcinoma should be restrained to patients with favourable tumours. Indications for segmental ureterectomy could be extended to selected individuals with more aggressive disease. These findings are limited by a selection bias.
AbstractList There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC).CONTEXTThere is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC).To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC.OBJECTIVETo systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC.A computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point.EVIDENCE ACQUISITIONA computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point.Seven studies compared KSS overall (n=547) versus RNU (n=1376). Information on the comparison of SU (n=586) versus RNU (n=3692), URS (n=162) versus RNU (n=367), and PC (n=66) versus RNU (n=114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS.EVIDENCE SYNTHESISSeven studies compared KSS overall (n=547) versus RNU (n=1376). Information on the comparison of SU (n=586) versus RNU (n=3692), URS (n=162) versus RNU (n=367), and PC (n=66) versus RNU (n=114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS.Our systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias.CONCLUSIONSOur systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias.We reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours.PATIENT SUMMARYWe reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours.
Abstract Context There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Objective To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC. Evidence acquisition A computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point. Evidence synthesis Seven studies compared KSS overall ( n = 547) versus RNU ( n = 1376). Information on the comparison of SU ( n = 586) versus RNU ( n = 3692), URS ( n = 162) versus RNU ( n = 367), and PC ( n = 66) versus RNU ( n = 114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS. Conclusions Our systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias. Patient summary We reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours.
There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC. A computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point. Seven studies compared KSS overall (n=547) versus RNU (n=1376). Information on the comparison of SU (n=586) versus RNU (n=3692), URS (n=162) versus RNU (n=367), and PC (n=66) versus RNU (n=114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS. Our systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias. We reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours.
There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC. A computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point. Seven studies compared KSS overall (n=547) versus RNU (n=1376). Information on the comparison of SU (n=586) versus RNU (n=3692), URS (n=162) versus RNU (n=367), and PC (n=66) versus RNU (n=114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS. Our systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias. We reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours. The use of endoscopic surgery for upper tract urothelial carcinoma should be restrained to patients with favourable tumours. Indications for segmental ureterectomy could be extended to selected individuals with more aggressive disease. These findings are limited by a selection bias.
Author Dominguez-Escrig, Jose Luis
Zigeuner, Richard
van Rhijn, Bas W.G.
Böhle, Andreas
Compérat, Eva M.
Yuan, Cathy Yuhong
Rouprêt, Morgan
Palou, Joan
Kaasinen, Eero
Seisen, Thomas
Cowan, Nigel C.
Peyronnet, Benoit
Bruins, Harman M.
Sylvester, Richard J.
Babjuk, Marko
Burger, Maximilian
Shariat, Shahrokh F.
Author_xml – sequence: 1
  givenname: Thomas
  surname: Seisen
  fullname: Seisen, Thomas
  email: thomas.seisen@gmail.com
  organization: Academic Department of Urology, Pitié-Salpétrière Hospital, Assistance-Publique Hôpitaux de Paris; Pierre et Marie Curie Medical School, University Paris 6, Paris, France
– sequence: 2
  givenname: Benoit
  surname: Peyronnet
  fullname: Peyronnet, Benoit
  organization: Department of Urology, University of Rennes, Rennes, France
– sequence: 3
  givenname: Jose Luis
  surname: Dominguez-Escrig
  fullname: Dominguez-Escrig, Jose Luis
  organization: Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain
– sequence: 4
  givenname: Harman M.
  surname: Bruins
  fullname: Bruins, Harman M.
  organization: Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
– sequence: 5
  givenname: Cathy Yuhong
  surname: Yuan
  fullname: Yuan, Cathy Yuhong
  organization: Department of Medicine, Division of Gastroenterology, McMaster University, Hamilton, ON, Canada
– sequence: 6
  givenname: Marko
  surname: Babjuk
  fullname: Babjuk, Marko
  organization: Department of Urology, Hospital Motol, Second Faculty of Medicine, Charles University, Praha, Czech Republic
– sequence: 7
  givenname: Andreas
  surname: Böhle
  fullname: Böhle, Andreas
  organization: Department of Urology, HELIOS Agnes-Karll-Krankenhaus, Bad Schwartau, Germany
– sequence: 8
  givenname: Maximilian
  surname: Burger
  fullname: Burger, Maximilian
  organization: Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany
– sequence: 9
  givenname: Eva M.
  surname: Compérat
  fullname: Compérat, Eva M.
  organization: Department of Pathology, Hôpital La Pitié-Salpétrière, UPMC, Paris, France
– sequence: 10
  givenname: Nigel C.
  surname: Cowan
  fullname: Cowan, Nigel C.
  organization: Radiology Department, Queen Alexandra Hospital, Portsmouth, UK
– sequence: 11
  givenname: Eero
  surname: Kaasinen
  fullname: Kaasinen, Eero
  organization: Department of Urology, Hyvinkää Hospital, Hyvinkää, Finland
– sequence: 12
  givenname: Joan
  surname: Palou
  fullname: Palou, Joan
  organization: Department of Urology, Fundació Puigvert, Universidad Autónoma de Barcelona, Barcelona, Spain
– sequence: 13
  givenname: Bas W.G.
  surname: van Rhijn
  fullname: van Rhijn, Bas W.G.
  organization: Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
– sequence: 14
  givenname: Richard J.
  surname: Sylvester
  fullname: Sylvester, Richard J.
  organization: European Association of Urology Guidelines Office, Brussels, Belgium
– sequence: 15
  givenname: Richard
  surname: Zigeuner
  fullname: Zigeuner, Richard
  organization: Department of Urology, Medical University of Graz, Graz, Austria
– sequence: 16
  givenname: Shahrokh F.
  surname: Shariat
  fullname: Shariat, Shahrokh F.
  organization: Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria
– sequence: 17
  givenname: Morgan
  surname: Rouprêt
  fullname: Rouprêt, Morgan
  organization: Academic Department of Urology, Pitié-Salpétrière Hospital, Assistance-Publique Hôpitaux de Paris; Pierre et Marie Curie Medical School, University Paris 6, Paris, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27477528$$D View this record in MEDLINE/PubMed
BookMark eNqVUl1r2zAUNaNjTbv9gzH0uBdnkr_klDHIQtuVlWY0zV6FIl2nymzJlewM_8L-rV2T9mUwykBwEZxz7uWccxIdWWchit4zOmWUFZ92U-h97900wd-U8ill2atowkqexjwv6FE0oSlN4qRMy-PoJIQdpTTNZ-mb6DjhGed5Uk6ix6VVrnZbo8iy75RrIBBXke9GWxji0Epv7Jaser8FP5Cf4EMfyK3URsma3EB7713voQMPqnPNQCrnybptwZM7L1VH1t5191AbRC-kV8a6Rp6ROVkNoYNGdrj3FvYGfpPNQBBJzudrcuNs3PRB1UCu7F4GswfytZZao-xCWoXjsjcaZS2e-0NaqN9GrytZB3j3NE-j9cX53eJbfL28vFrMr2OVp0UX55zqBPJS8TQpy7SqFKtozjmrmMwryTY6YTTVFRpU6hmt8ozqTEFRZlmh8KWn0ceDbuvdQw-hE40JCuoaj3B9EKxMCp6h0wVCPzxB-00DWrTeNNIP4tl8BJwdAMq7EDxUQpkOLXG289LUglExJi124pC0GJMWlAtMGsnZX-Rn_RdoXw40QJPQdy-CMoCWajNGKLQz_yugMIaxDr9ggLDDOlgMQDAREkHFauzgWEFWpDRjsxwFPv9b4OX9fwB5VvG1
CitedBy_id crossref_primary_10_3390_cancers16223795
crossref_primary_10_3389_fonc_2023_944321
crossref_primary_10_3389_fonc_2024_1426003
crossref_primary_10_1097_MOU_0000000000000598
crossref_primary_10_4103_UROS_UROS_49_20
crossref_primary_10_1002_cncr_30516
crossref_primary_10_1093_jjco_hyad152
crossref_primary_10_1016_j_eururo_2016_09_028
crossref_primary_10_1007_s00345_023_04689_1
crossref_primary_10_1016_j_eururo_2016_09_027
crossref_primary_10_1002_bco2_502
crossref_primary_10_3390_cancers15184585
crossref_primary_10_1080_21681805_2022_2107065
crossref_primary_10_1016_j_canlet_2021_02_010
crossref_primary_10_1002_tre_947
crossref_primary_10_1016_j_urology_2021_06_053
crossref_primary_10_1007_s00761_022_01220_w
crossref_primary_10_3390_ijms23052602
crossref_primary_10_1080_14737140_2019_1698295
crossref_primary_10_1111_iju_14336
crossref_primary_10_1177_11795549221147993
crossref_primary_10_3389_fonc_2022_825476
crossref_primary_10_1080_2090598X_2021_1883810
crossref_primary_10_1007_s00345_022_04156_3
crossref_primary_10_1007_s00761_024_01626_8
crossref_primary_10_1016_j_urolonc_2024_04_021
crossref_primary_10_23736_S2724_6051_23_05593_3
crossref_primary_10_3389_fonc_2022_858813
crossref_primary_10_3390_cancers16223772
crossref_primary_10_1007_s00432_023_05207_x
crossref_primary_10_3390_pr9122136
crossref_primary_10_1007_s00120_020_01323_5
crossref_primary_10_1016_j_urolonc_2020_08_004
crossref_primary_10_2147_CMAR_S259964
crossref_primary_10_3389_fonc_2022_872432
crossref_primary_10_1016_j_ijbiomac_2024_135608
crossref_primary_10_1016_j_urolonc_2023_09_019
crossref_primary_10_1016_j_conctc_2018_01_007
crossref_primary_10_1007_s00345_019_02811_w
crossref_primary_10_1111_ctr_13559
crossref_primary_10_1007_s00345_018_2506_1
crossref_primary_10_1016_j_euros_2022_04_007
crossref_primary_10_1016_j_clgc_2023_11_015
crossref_primary_10_1186_s12885_024_12913_3
crossref_primary_10_4103_UROS_UROS_54_22
crossref_primary_10_1177_2050313X231176356
crossref_primary_10_3390_cancers15184495
crossref_primary_10_3390_jcm11195815
crossref_primary_10_1016_j_humpath_2022_03_004
crossref_primary_10_1111_bju_15494
crossref_primary_10_3390_jcm13216593
crossref_primary_10_1186_s12894_023_01265_y
crossref_primary_10_1245_s10434_024_16757_w
crossref_primary_10_3389_fonc_2022_769252
crossref_primary_10_1097_CU9_0000000000000164
crossref_primary_10_1007_s00432_023_05264_2
crossref_primary_10_1148_rg_240056
crossref_primary_10_3390_biomedicines11071775
crossref_primary_10_1016_j_eururo_2021_05_004
crossref_primary_10_3390_cancers15061874
crossref_primary_10_3389_fonc_2023_1225428
crossref_primary_10_1177_1758835920937950
crossref_primary_10_1016_j_urolonc_2019_02_004
crossref_primary_10_1016_j_urolonc_2020_03_005
crossref_primary_10_1097_CU9_0000000000000158
crossref_primary_10_1016_j_urolonc_2022_02_016
crossref_primary_10_1016_j_euros_2021_08_003
crossref_primary_10_3390_cancers15205020
crossref_primary_10_1016_j_asjsur_2022_04_077
crossref_primary_10_1080_21681805_2022_2091018
crossref_primary_10_1007_s00345_019_02790_y
crossref_primary_10_1186_s12894_024_01439_2
crossref_primary_10_1007_s11255_020_02439_5
crossref_primary_10_12998_wjcc_v9_i8_1916
crossref_primary_10_1016_j_euros_2021_08_002
crossref_primary_10_1038_s41598_021_83495_4
crossref_primary_10_3389_fonc_2024_1419882
crossref_primary_10_1080_14737140_2019_1621753
crossref_primary_10_1089_end_2019_0725
crossref_primary_10_1016_j_eururo_2020_05_042
crossref_primary_10_1016_j_urology_2018_10_004
crossref_primary_10_1016_j_heliyon_2023_e22408
crossref_primary_10_1016_j_urolonc_2023_08_013
crossref_primary_10_3390_curroncol29120727
crossref_primary_10_1016_j_urolonc_2024_05_019
crossref_primary_10_1016_j_purol_2019_01_005
crossref_primary_10_1007_s00345_023_04693_5
crossref_primary_10_1111_iju_13826
crossref_primary_10_1111_iju_15208
crossref_primary_10_1007_s11912_023_01460_y
crossref_primary_10_1093_jscr_rjab544
crossref_primary_10_1136_esmoopen_2016_000126
crossref_primary_10_1016_j_ajur_2024_08_003
crossref_primary_10_1186_s12894_020_00744_w
crossref_primary_10_1097_MD_0000000000022176
crossref_primary_10_1007_s00345_020_03124_z
crossref_primary_10_1002_btm2_10353
crossref_primary_10_1016_j_hoc_2021_02_005
crossref_primary_10_5301_tj_5000705
crossref_primary_10_1016_j_asjsur_2025_01_004
crossref_primary_10_3390_ijms20133162
crossref_primary_10_1016_j_acuroe_2018_07_002
crossref_primary_10_1016_j_purol_2022_08_003
crossref_primary_10_1007_s00261_019_02293_9
crossref_primary_10_1016_j_urology_2019_10_005
crossref_primary_10_1016_j_clgc_2018_01_015
crossref_primary_10_1016_j_eururo_2023_03_013
crossref_primary_10_3390_uro2010003
crossref_primary_10_1016_j_urolonc_2023_04_010
crossref_primary_10_1002_cam4_5544
crossref_primary_10_1016_j_acuro_2018_01_010
crossref_primary_10_1007_s11912_021_01179_8
crossref_primary_10_1016_j_urolonc_2022_11_020
crossref_primary_10_1016_j_euf_2025_01_009
crossref_primary_10_1016_j_pdpdt_2020_102067
crossref_primary_10_1089_end_2024_0061
crossref_primary_10_1111_iju_13522
crossref_primary_10_1200_EDBK_237451
crossref_primary_10_1177_1179554920927662
crossref_primary_10_1016_j_humpath_2021_09_007
crossref_primary_10_3390_jpm13040591
crossref_primary_10_1080_21681805_2021_1916073
crossref_primary_10_3390_cancers14163962
crossref_primary_10_1177_03008916231186178
crossref_primary_10_1200_JCO_2016_69_4141
crossref_primary_10_1016_j_euf_2023_05_012
crossref_primary_10_3390_jcm12154907
crossref_primary_10_1016_j_conctc_2022_100902
crossref_primary_10_3390_cancers16010044
crossref_primary_10_1016_S1636_5577_22_46926_4
crossref_primary_10_1007_s13691_020_00402_w
crossref_primary_10_1038_nrurol_2017_203
crossref_primary_10_1111_bju_15925
crossref_primary_10_1016_j_urology_2021_03_003
crossref_primary_10_3390_ijms23116305
crossref_primary_10_3389_fonc_2023_1143030
crossref_primary_10_1186_s12894_023_01387_3
crossref_primary_10_1016_j_urology_2020_09_036
crossref_primary_10_1016_j_fjurol_2024_102722
crossref_primary_10_1038_s41598_021_87573_5
crossref_primary_10_1007_s00345_024_05032_y
crossref_primary_10_1093_jjco_hyaa132
crossref_primary_10_3389_fonc_2022_889028
crossref_primary_10_3390_pharmaceutics16081067
crossref_primary_10_1097_MOU_0000000000001078
crossref_primary_10_3233_BLC_220093
crossref_primary_10_1089_end_2021_0133
crossref_primary_10_1007_s00345_024_05222_8
crossref_primary_10_3389_fonc_2022_907975
crossref_primary_10_1016_j_eururo_2025_02_023
crossref_primary_10_1016_S1166_7087_20_30750_8
crossref_primary_10_1245_s10434_021_10233_5
crossref_primary_10_1186_s12894_024_01629_y
crossref_primary_10_3389_fonc_2024_1406031
crossref_primary_10_1002_lsm_23079
crossref_primary_10_1016_j_euo_2021_09_002
crossref_primary_10_1016_j_urology_2020_06_083
crossref_primary_10_1097_MOU_0000000000001248
crossref_primary_10_1007_s00345_019_02682_1
crossref_primary_10_1007_s00345_023_04687_3
crossref_primary_10_4103_iju_IJU_93_20
crossref_primary_10_1097_MOU_0000000000001240
crossref_primary_10_1245_s10434_024_16523_y
crossref_primary_10_1097_MOU_0000000000001120
crossref_primary_10_1007_s00345_019_02739_1
crossref_primary_10_1007_s00120_024_02422_3
crossref_primary_10_1016_j_clgc_2019_10_015
crossref_primary_10_1016_j_eucr_2021_101944
crossref_primary_10_1186_s12906_020_2861_5
crossref_primary_10_1007_s40336_020_00378_w
crossref_primary_10_1016_j_ucl_2020_09_011
crossref_primary_10_1111_bju_14697
crossref_primary_10_1016_j_clgc_2020_09_002
crossref_primary_10_1016_j_urolonc_2022_10_029
crossref_primary_10_1002_iju5_12534
crossref_primary_10_1016_j_juro_2017_07_088
crossref_primary_10_1007_s11255_019_02230_1
crossref_primary_10_1089_end_2023_0092
crossref_primary_10_3390_jcm11051307
crossref_primary_10_1111_ases_13216
crossref_primary_10_23736_S2724_6051_24_05737_9
crossref_primary_10_1186_s12957_021_02297_0
crossref_primary_10_3390_cancers15215122
crossref_primary_10_1007_s11255_023_03838_0
crossref_primary_10_23736_S2724_6051_23_05354_5
crossref_primary_10_1080_14737140_2018_1481395
crossref_primary_10_2196_15363
crossref_primary_10_1016_j_euros_2024_06_005
crossref_primary_10_1016_j_purol_2018_07_284
crossref_primary_10_1089_end_2024_0654
crossref_primary_10_1186_s12894_019_0557_2
crossref_primary_10_1016_j_urolonc_2017_05_009
crossref_primary_10_1080_21681805_2022_2041086
crossref_primary_10_1016_j_urolonc_2024_03_012
crossref_primary_10_3389_fruro_2022_903693
crossref_primary_10_24060_2076_3093_2021_11_4_323_327
crossref_primary_10_1007_s00262_020_02827_x
crossref_primary_10_1016_j_fpurol_2024_07_206
crossref_primary_10_1007_s00120_024_02421_4
crossref_primary_10_1016_j_eururo_2017_07_036
crossref_primary_10_1111_bju_15566
crossref_primary_10_1016_S1761_3310_22_46063_4
crossref_primary_10_1155_2018_2793172
crossref_primary_10_1038_s41598_024_77117_y
crossref_primary_10_1007_s00345_019_02646_5
crossref_primary_10_1016_j_euf_2022_11_016
crossref_primary_10_1016_S1761_3310_22_47076_9
crossref_primary_10_1038_s41585_022_00613_1
crossref_primary_10_1007_s00345_019_02768_w
crossref_primary_10_17650_1726_9776_2021_17_2_104_111
crossref_primary_10_1039_c8pp00409a
crossref_primary_10_1186_s12894_023_01279_6
crossref_primary_10_1007_s00345_017_2139_9
crossref_primary_10_3389_fsurg_2021_790738
crossref_primary_10_3389_fonc_2021_699210
Cites_doi 10.1136/bmj.d5928
10.1089/end.2010.0276
10.1111/iju.12554
10.1007/s12094-012-0800-8
10.1186/1471-2490-14-97
10.1016/j.urology.2008.06.026
10.1111/bju.12341
10.1159/000209368
10.1097/MOU.0000000000000148
10.5489/cuaj.2408
10.1111/j.1464-410X.2012.11068.x
10.1016/j.eururo.2004.01.021
10.1016/j.eururo.2015.06.044
10.1111/j.1464-410X.2012.11199.x
10.1111/j.1464-410X.2011.10363.x
10.1016/j.eururo.2013.12.007
10.1007/s11255-013-0514-z
10.1016/j.urolonc.2013.01.001
10.1016/j.ejca.2009.06.016
10.1016/j.eururo.2014.09.027
10.1089/end.1999.13.289
10.1089/end.2015.0044
10.1089/end.2008.0251
10.1007/s00345-012-0948-4
10.7314/APJCP.2015.16.14.5907
10.1111/j.1464-410X.2012.11066.x
10.1111/j.1464-410X.2012.10960.x
10.1016/j.juro.2010.02.005
10.1016/j.urology.2005.12.034
10.3322/caac.21332
10.1016/j.eururo.2012.10.020
10.1016/j.juro.2012.12.006
10.1016/j.ejso.2014.06.007
10.1016/j.juro.2011.09.150
10.1016/j.urology.2012.12.059
10.1016/j.urolonc.2015.03.006
10.1111/j.1464-410X.2007.06993.x
10.1136/bmj.b2535
10.1038/nrurol.2015.24
10.1111/j.1464-410X.2008.07535.x
10.1016/j.juro.2015.11.036
ContentType Journal Article
Copyright 2016 European Association of Urology
European Association of Urology
Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2016 European Association of Urology
– notice: European Association of Urology
– notice: Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.eururo.2016.07.014
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1873-7560
EndPage 1068
ExternalDocumentID 27477528
10_1016_j_eururo_2016_07_014
S0302283816304195
1_s2_0_S0302283816304195
Genre Systematic Review
Journal Article
Comparative Study
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
0~B
1B1
1P~
1~.
1~5
29G
30W
34G
39C
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
8UI
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYIC
AAYWO
ABBQC
ABBTS
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABWCG
ABWVN
ABXDB
ACDAQ
ACIEU
ACQXL
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEYAO
AFJKZ
AFPUW
AFRHN
AFSIO
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
CYUIP
DU5
E0A
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FB.
FDB
FEDTE
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O1H
O9-
OAUVE
OK.
OW.
OZT
P-8
P-9
P2P
PC.
Q38
RKO
ROL
RPZ
SCC
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
UDS
UJ6
UV1
X7M
Z5R
ZGI
ZXP
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
AZPMC
EFLBG
LCYCR
ZA5
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ACLOT
~HD
ID FETCH-LOGICAL-c536t-570d2e58c732883ffc1f05771f1a5fa1bd2103df2748d90f540d4ce68446c46c3
IEDL.DBID AIKHN
ISSN 0302-2838
1873-7560
IngestDate Sun Sep 28 06:31:08 EDT 2025
Mon Jul 21 06:07:45 EDT 2025
Tue Jul 01 02:55:24 EDT 2025
Thu Apr 24 23:02:12 EDT 2025
Fri Feb 23 02:16:44 EST 2024
Tue Feb 25 20:12:31 EST 2025
Tue Aug 26 17:11:57 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Ureteral neoplasms
Recurrence
Renal pelvis
Ureter
Ureteroscopy
Urinary tract
Urothelial carcinoma
Survival
Language English
License Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-570d2e58c732883ffc1f05771f1a5fa1bd2103df2748d90f540d4ce68446c46c3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
PMID 27477528
PQID 1826740006
PQPubID 23479
PageCount 17
ParticipantIDs proquest_miscellaneous_1826740006
pubmed_primary_27477528
crossref_citationtrail_10_1016_j_eururo_2016_07_014
crossref_primary_10_1016_j_eururo_2016_07_014
elsevier_sciencedirect_doi_10_1016_j_eururo_2016_07_014
elsevier_clinicalkeyesjournals_1_s2_0_S0302283816304195
elsevier_clinicalkey_doi_10_1016_j_eururo_2016_07_014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-12-01
PublicationDateYYYYMMDD 2016-12-01
PublicationDate_xml – month: 12
  year: 2016
  text: 2016-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle European urology
PublicationTitleAlternate Eur Urol
PublicationYear 2016
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Cutress, Stewart, Tudor (bib0285) 2013; 189
Rastinehad, Ost, Vanderbrink (bib0385) 2009; 73
Hoffman, Yossepowitch, Erlich (bib0270) 2014; 14
Lughezzani, Jeldres, Isbarn (bib0330) 2009; 45
Siegel, Miller, Jemal (bib0210) 2016; 66
Colin, Ouzzane, Pignot (bib0295) 2012; 110
Lee, Jabbour, Marshall (bib0355) 1999; 13
Bin, Roy, Ghiraldi (bib0300) 2012; 110
Treuthardt, Danuser, Studer (bib0380) 2004; 46
Simhan, Smaldone, Egleston (bib0255) 2014; 114
Bing-bing, Cheng, Han-zhong (bib0310) 2012; 14
Pak, Moskowitz, Bagley (bib0390) 2009; 23
Dalpiaz, Ehrlich, Quehenberger (bib0265) 2014; 32
Higgins, Altman, Gøtzsche (bib0360) 2011; 343
Gadzinski, Roberts, Faerber (bib0325) 2010; 183
Dragicevic, Djokic, Pekmezovic (bib0335) 2009; 82
Giannarini, Schumacher, Thalmann (bib0345) 2007; 100
Grasso, Fishman, Cohen (bib0305) 2012; 110
Rouprêt, Babjuk, Compérat (bib0215) 2015; 68
Luo, She, Xiong (bib0410) 2015; 16
Audenet, Traxer, Yates (bib0220) 2012; 109
Cutress, Stewart, Zakikhani (bib0375) 2012; 110
Silberstein, Power, Savage (bib0315) 2012; 187
Fukushima, Saito, Ishioka (bib0275) 2014; 21
Seisen, Nison, Remzi (bib0365) 2016; 195
Singla, Gayed, Bagrodia (bib0395) 2015; 33
Yakoubi, Colin, Seisen (bib0405) 2014; 40
Seisen, Colin, Rouprêt (bib0225) 2015; 12
Colin, Rouprêt, Ghoneim (bib0235) 2013; 63
Moher, Liberati, Tetzlaff, Altman (bib0245) 2009; 339
Fajkovic, Klatte, Nagele (bib0280) 2013; 31
Lucas, Svatek, Olgin (bib0340) 2008; 102
Haddad, Cloutier, Cornu (bib0370) 2015; 29
Raymundo, Lipkin, Bañez (bib0320) 2011; 25
Bagrodia, Kuehhas, Gayed (bib0290) 2013; 81
Pedrosa, Masterson, Rice (bib0250) 2015; 9
Rouprêt, Hupertan, Traxer (bib0350) 2006; 67
Lucca, Klatte, Rouprêt, Shariat (bib0400) 2015; 25
Hung, Yang, Luo (bib0260) 2014; 46
Capitanio, Terrone, Antonelli (bib0230) 2015; 67
Rouprêt, Colin, Yates (bib0240) 2014; 66
Simhan (10.1016/j.eururo.2016.07.014_bib0255) 2014; 114
Cutress (10.1016/j.eururo.2016.07.014_bib0375) 2012; 110
Singla (10.1016/j.eururo.2016.07.014_bib0395) 2015; 33
Seisen (10.1016/j.eururo.2016.07.014_bib0365) 2016; 195
Treuthardt (10.1016/j.eururo.2016.07.014_bib0380) 2004; 46
Dalpiaz (10.1016/j.eururo.2016.07.014_bib0265) 2014; 32
Fajkovic (10.1016/j.eururo.2016.07.014_bib0280) 2013; 31
Dragicevic (10.1016/j.eururo.2016.07.014_bib0335) 2009; 82
Pak (10.1016/j.eururo.2016.07.014_bib0390) 2009; 23
Lucas (10.1016/j.eururo.2016.07.014_bib0340) 2008; 102
Luo (10.1016/j.eururo.2016.07.014_bib0410) 2015; 16
Rastinehad (10.1016/j.eururo.2016.07.014_bib0385) 2009; 73
Bin (10.1016/j.eururo.2016.07.014_bib0300) 2012; 110
Rouprêt (10.1016/j.eururo.2016.07.014_bib0215) 2015; 68
Yakoubi (10.1016/j.eururo.2016.07.014_bib0405) 2014; 40
Siegel (10.1016/j.eururo.2016.07.014_bib0210) 2016; 66
Giannarini (10.1016/j.eururo.2016.07.014_bib0345) 2007; 100
Hung (10.1016/j.eururo.2016.07.014_bib0260) 2014; 46
Colin (10.1016/j.eururo.2016.07.014_bib0235) 2013; 63
Seisen (10.1016/j.eururo.2016.07.014_bib0225) 2015; 12
Lucca (10.1016/j.eururo.2016.07.014_bib0400) 2015; 25
Raymundo (10.1016/j.eururo.2016.07.014_bib0320) 2011; 25
Rouprêt (10.1016/j.eururo.2016.07.014_bib0350) 2006; 67
Silberstein (10.1016/j.eururo.2016.07.014_bib0315) 2012; 187
Lee (10.1016/j.eururo.2016.07.014_bib0355) 1999; 13
Capitanio (10.1016/j.eururo.2016.07.014_bib0230) 2015; 67
Hoffman (10.1016/j.eururo.2016.07.014_bib0270) 2014; 14
Lughezzani (10.1016/j.eururo.2016.07.014_bib0330) 2009; 45
Haddad (10.1016/j.eururo.2016.07.014_bib0370) 2015; 29
Moher (10.1016/j.eururo.2016.07.014_bib0245) 2009; 339
Bagrodia (10.1016/j.eururo.2016.07.014_bib0290) 2013; 81
Pedrosa (10.1016/j.eururo.2016.07.014_bib0250) 2015; 9
Audenet (10.1016/j.eururo.2016.07.014_bib0220) 2012; 109
Grasso (10.1016/j.eururo.2016.07.014_bib0305) 2012; 110
Bing-bing (10.1016/j.eururo.2016.07.014_bib0310) 2012; 14
Colin (10.1016/j.eururo.2016.07.014_bib0295) 2012; 110
Cutress (10.1016/j.eururo.2016.07.014_bib0285) 2013; 189
Rouprêt (10.1016/j.eururo.2016.07.014_bib0240) 2014; 66
Gadzinski (10.1016/j.eururo.2016.07.014_bib0325) 2010; 183
Fukushima (10.1016/j.eururo.2016.07.014_bib0275) 2014; 21
Higgins (10.1016/j.eururo.2016.07.014_bib0360) 2011; 343
28505892 - J Urol. 2017 Jun;197(6):1437-1438. doi: 10.1016/j.juro.2017.03.046.
27687822 - Eur Urol. 2017 Apr;71(4):e109-e110. doi: 10.1016/j.eururo.2016.09.028.
27666997 - Eur Urol. 2017 Apr;71(4):e111-e112. doi: 10.1016/j.eururo.2016.09.027.
References_xml – volume: 12
  start-page: 155
  year: 2015
  end-page: 166
  ident: bib0225
  article-title: Risk-adapted strategy for the kidney-sparing management of upper tract tumours
  publication-title: Nat Rev Urol
– volume: 31
  start-page: 37
  year: 2013
  end-page: 44
  ident: bib0280
  article-title: Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience
  publication-title: World J Urol
– volume: 100
  start-page: 264
  year: 2007
  end-page: 268
  ident: bib0345
  article-title: Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised?
  publication-title: BJU Int
– volume: 66
  start-page: 7
  year: 2016
  end-page: 30
  ident: bib0210
  article-title: Cancer statistics, 2016
  publication-title: CA Cancer J Clin
– volume: 73
  start-page: 27
  year: 2009
  end-page: 31
  ident: bib0385
  article-title: A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy?
  publication-title: Urology
– volume: 23
  start-page: 341
  year: 2009
  end-page: 346
  ident: bib0390
  article-title: What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival
  publication-title: J Endourol
– volume: 339
  start-page: b2535
  year: 2009
  ident: bib0245
  article-title: PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
  publication-title: BMJ
– volume: 82
  start-page: 335
  year: 2009
  end-page: 340
  ident: bib0335
  article-title: Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma
  publication-title: Urol Int
– volume: 81
  start-page: 972
  year: 2013
  end-page: 977
  ident: bib0290
  article-title: Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma
  publication-title: Urology
– volume: 67
  start-page: 1181
  year: 2006
  end-page: 1187
  ident: bib0350
  article-title: Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma
  publication-title: Urology
– volume: 109
  start-page: 608
  year: 2012
  end-page: 613
  ident: bib0220
  article-title: Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract
  publication-title: BJU Int
– volume: 14
  start-page: 97
  year: 2014
  ident: bib0270
  article-title: Oncologic results of nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy - a case control study
  publication-title: BMC Urol
– volume: 46
  start-page: 442
  year: 2004
  end-page: 443
  ident: bib0380
  article-title: Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis
  publication-title: Eur Urol
– volume: 189
  start-page: 2054
  year: 2013
  end-page: 2060
  ident: bib0285
  article-title: Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience
  publication-title: J Urol
– volume: 46
  start-page: 921
  year: 2014
  end-page: 926
  ident: bib0260
  article-title: Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer
  publication-title: Int Urol Nephrol
– volume: 29
  start-page: 969
  year: 2015
  end-page: 973
  ident: bib0370
  article-title: Immediate nephroureterectomy or after attempting conservative treatment, on elective indications, for upper urinary tract urothelial carcinoma: comparison of the pathology reports on a retrospective monocentric study
  publication-title: J Endourol
– volume: 25
  start-page: 377
  year: 2011
  end-page: 384
  ident: bib0320
  article-title: Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma
  publication-title: J Endourol
– volume: 21
  start-page: 1098
  year: 2014
  end-page: 1104
  ident: bib0275
  article-title: Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter study
  publication-title: Int J Urol
– volume: 110
  start-page: E514
  year: 2012
  end-page: E519
  ident: bib0300
  article-title: Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours
  publication-title: BJU Int
– volume: 110
  start-page: 614
  year: 2012
  end-page: 628
  ident: bib0375
  article-title: Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review
  publication-title: BJU Int
– volume: 32
  start-page: 34.e1
  year: 2014
  end-page: 34.e8
  ident: bib0265
  article-title: Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter
  publication-title: Urol Oncol
– volume: 68
  start-page: 868
  year: 2015
  end-page: 879
  ident: bib0215
  article-title: European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update
  publication-title: Eur Urol
– volume: 110
  start-page: 1618
  year: 2012
  end-page: 1626
  ident: bib0305
  article-title: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients
  publication-title: BJU Int
– volume: 33
  start-page: 268.e1
  year: 2015
  end-page: 268.e7
  ident: bib0395
  article-title: Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma
  publication-title: Urol Oncol
– volume: 195
  start-page: 1354
  year: 2016
  end-page: 1361
  ident: bib0365
  article-title: Oncologic outcomes of kidney-sparing surgery versus kidney sparing surgery for the elective treatment of clinically organ confined upper tract urothelial carcinoma of the distal ureter
  publication-title: J Urol
– volume: 102
  start-page: 172
  year: 2008
  end-page: 176
  ident: bib0340
  article-title: Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery
  publication-title: BJU Int
– volume: 16
  start-page: 5907
  year: 2015
  end-page: 5912
  ident: bib0410
  article-title: Kidney-sparing management versus nephroureterectomy for upper tract urothelial carcinoma: a systematic review and meta-analysis
  publication-title: Asian Pac J Cancer Prev
– volume: 66
  start-page: 181
  year: 2014
  end-page: 183
  ident: bib0240
  article-title: A new proposal to risk stratify urothelial carcinomas of the upper urinary tract (UTUCs) in a predefinitive treatment setting: low-risk versus high-risk UTUCs
  publication-title: Eur Urol
– volume: 40
  start-page: 1629
  year: 2014
  end-page: 1634
  ident: bib0405
  article-title: Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies
  publication-title: Eur J Surg Oncol
– volume: 14
  start-page: 312
  year: 2012
  end-page: 316
  ident: bib0310
  article-title: Correlation between surgical modality and clinicopathologic characteristics for ureteral transitional cell carcinoma
  publication-title: Clin Transl Oncol
– volume: 9
  start-page: E187
  year: 2015
  end-page: E192
  ident: bib0250
  article-title: Oncologic outcomes and prognostic impact of urothelial recurrences in patients undergoing segmental and total ureterectomy for upper tract urothelial carcinoma
  publication-title: Can Urol Assoc J
– volume: 114
  start-page: 216
  year: 2014
  end-page: 220
  ident: bib0255
  article-title: Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma
  publication-title: BJU Int
– volume: 187
  start-page: 429
  year: 2012
  end-page: 434
  ident: bib0315
  article-title: Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma
  publication-title: J Urol
– volume: 67
  start-page: 683
  year: 2015
  end-page: 689
  ident: bib0230
  article-title: Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with T1a-T1b renal mass and normal preoperative renal function
  publication-title: Eur Urol
– volume: 183
  start-page: 2148
  year: 2010
  end-page: 2153
  ident: bib0325
  article-title: Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma
  publication-title: J Urol
– volume: 343
  start-page: d5928
  year: 2011
  ident: bib0360
  article-title: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
  publication-title: BMJ
– volume: 45
  start-page: 3291
  year: 2009
  end-page: 3297
  ident: bib0330
  article-title: Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients
  publication-title: Eur J Cancer
– volume: 25
  start-page: 100
  year: 2015
  end-page: 104
  ident: bib0400
  article-title: Kidney-sparing surgery for upper tract urothelial cancer
  publication-title: Curr Opin Urol
– volume: 63
  start-page: 405
  year: 2013
  end-page: 406
  ident: bib0235
  article-title: Conservative management of upper tract urothelial carcinoma in France: a 2004-2011 national practice report
  publication-title: Eur Urol
– volume: 13
  start-page: 289
  year: 1999
  end-page: 294
  ident: bib0355
  article-title: 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes
  publication-title: J Endourol
– volume: 110
  start-page: 1134
  year: 2012
  end-page: 1141
  ident: bib0295
  article-title: Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study
  publication-title: BJU Int
– volume: 343
  start-page: d5928
  year: 2011
  ident: 10.1016/j.eururo.2016.07.014_bib0360
  article-title: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
  publication-title: BMJ
  doi: 10.1136/bmj.d5928
– volume: 25
  start-page: 377
  year: 2011
  ident: 10.1016/j.eururo.2016.07.014_bib0320
  article-title: Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma
  publication-title: J Endourol
  doi: 10.1089/end.2010.0276
– volume: 21
  start-page: 1098
  year: 2014
  ident: 10.1016/j.eururo.2016.07.014_bib0275
  article-title: Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter study
  publication-title: Int J Urol
  doi: 10.1111/iju.12554
– volume: 14
  start-page: 312
  year: 2012
  ident: 10.1016/j.eururo.2016.07.014_bib0310
  article-title: Correlation between surgical modality and clinicopathologic characteristics for ureteral transitional cell carcinoma
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-012-0800-8
– volume: 14
  start-page: 97
  year: 2014
  ident: 10.1016/j.eururo.2016.07.014_bib0270
  article-title: Oncologic results of nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy - a case control study
  publication-title: BMC Urol
  doi: 10.1186/1471-2490-14-97
– volume: 73
  start-page: 27
  year: 2009
  ident: 10.1016/j.eururo.2016.07.014_bib0385
  article-title: A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy?
  publication-title: Urology
  doi: 10.1016/j.urology.2008.06.026
– volume: 114
  start-page: 216
  year: 2014
  ident: 10.1016/j.eururo.2016.07.014_bib0255
  article-title: Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma
  publication-title: BJU Int
  doi: 10.1111/bju.12341
– volume: 82
  start-page: 335
  year: 2009
  ident: 10.1016/j.eururo.2016.07.014_bib0335
  article-title: Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma
  publication-title: Urol Int
  doi: 10.1159/000209368
– volume: 25
  start-page: 100
  year: 2015
  ident: 10.1016/j.eururo.2016.07.014_bib0400
  article-title: Kidney-sparing surgery for upper tract urothelial cancer
  publication-title: Curr Opin Urol
  doi: 10.1097/MOU.0000000000000148
– volume: 9
  start-page: E187
  year: 2015
  ident: 10.1016/j.eururo.2016.07.014_bib0250
  article-title: Oncologic outcomes and prognostic impact of urothelial recurrences in patients undergoing segmental and total ureterectomy for upper tract urothelial carcinoma
  publication-title: Can Urol Assoc J
  doi: 10.5489/cuaj.2408
– volume: 110
  start-page: 614
  year: 2012
  ident: 10.1016/j.eururo.2016.07.014_bib0375
  article-title: Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2012.11068.x
– volume: 46
  start-page: 442
  year: 2004
  ident: 10.1016/j.eururo.2016.07.014_bib0380
  article-title: Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2004.01.021
– volume: 68
  start-page: 868
  year: 2015
  ident: 10.1016/j.eururo.2016.07.014_bib0215
  article-title: European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2015.06.044
– volume: 110
  start-page: E514
  year: 2012
  ident: 10.1016/j.eururo.2016.07.014_bib0300
  article-title: Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2012.11199.x
– volume: 109
  start-page: 608
  year: 2012
  ident: 10.1016/j.eururo.2016.07.014_bib0220
  article-title: Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2011.10363.x
– volume: 66
  start-page: 181
  year: 2014
  ident: 10.1016/j.eururo.2016.07.014_bib0240
  article-title: A new proposal to risk stratify urothelial carcinomas of the upper urinary tract (UTUCs) in a predefinitive treatment setting: low-risk versus high-risk UTUCs
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2013.12.007
– volume: 46
  start-page: 921
  year: 2014
  ident: 10.1016/j.eururo.2016.07.014_bib0260
  article-title: Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer
  publication-title: Int Urol Nephrol
  doi: 10.1007/s11255-013-0514-z
– volume: 32
  start-page: 34.e1
  year: 2014
  ident: 10.1016/j.eururo.2016.07.014_bib0265
  article-title: Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter
  publication-title: Urol Oncol
  doi: 10.1016/j.urolonc.2013.01.001
– volume: 45
  start-page: 3291
  year: 2009
  ident: 10.1016/j.eururo.2016.07.014_bib0330
  article-title: Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2009.06.016
– volume: 67
  start-page: 683
  year: 2015
  ident: 10.1016/j.eururo.2016.07.014_bib0230
  article-title: Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with T1a-T1b renal mass and normal preoperative renal function
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2014.09.027
– volume: 13
  start-page: 289
  year: 1999
  ident: 10.1016/j.eururo.2016.07.014_bib0355
  article-title: 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes
  publication-title: J Endourol
  doi: 10.1089/end.1999.13.289
– volume: 29
  start-page: 969
  year: 2015
  ident: 10.1016/j.eururo.2016.07.014_bib0370
  article-title: Immediate nephroureterectomy or after attempting conservative treatment, on elective indications, for upper urinary tract urothelial carcinoma: comparison of the pathology reports on a retrospective monocentric study
  publication-title: J Endourol
  doi: 10.1089/end.2015.0044
– volume: 23
  start-page: 341
  year: 2009
  ident: 10.1016/j.eururo.2016.07.014_bib0390
  article-title: What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival
  publication-title: J Endourol
  doi: 10.1089/end.2008.0251
– volume: 31
  start-page: 37
  year: 2013
  ident: 10.1016/j.eururo.2016.07.014_bib0280
  article-title: Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience
  publication-title: World J Urol
  doi: 10.1007/s00345-012-0948-4
– volume: 16
  start-page: 5907
  year: 2015
  ident: 10.1016/j.eururo.2016.07.014_bib0410
  article-title: Kidney-sparing management versus nephroureterectomy for upper tract urothelial carcinoma: a systematic review and meta-analysis
  publication-title: Asian Pac J Cancer Prev
  doi: 10.7314/APJCP.2015.16.14.5907
– volume: 110
  start-page: 1618
  year: 2012
  ident: 10.1016/j.eururo.2016.07.014_bib0305
  article-title: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2012.11066.x
– volume: 110
  start-page: 1134
  year: 2012
  ident: 10.1016/j.eururo.2016.07.014_bib0295
  article-title: Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2012.10960.x
– volume: 183
  start-page: 2148
  year: 2010
  ident: 10.1016/j.eururo.2016.07.014_bib0325
  article-title: Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma
  publication-title: J Urol
  doi: 10.1016/j.juro.2010.02.005
– volume: 67
  start-page: 1181
  year: 2006
  ident: 10.1016/j.eururo.2016.07.014_bib0350
  article-title: Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma
  publication-title: Urology
  doi: 10.1016/j.urology.2005.12.034
– volume: 66
  start-page: 7
  year: 2016
  ident: 10.1016/j.eururo.2016.07.014_bib0210
  article-title: Cancer statistics, 2016
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21332
– volume: 63
  start-page: 405
  year: 2013
  ident: 10.1016/j.eururo.2016.07.014_bib0235
  article-title: Conservative management of upper tract urothelial carcinoma in France: a 2004-2011 national practice report
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2012.10.020
– volume: 189
  start-page: 2054
  year: 2013
  ident: 10.1016/j.eururo.2016.07.014_bib0285
  article-title: Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience
  publication-title: J Urol
  doi: 10.1016/j.juro.2012.12.006
– volume: 40
  start-page: 1629
  year: 2014
  ident: 10.1016/j.eururo.2016.07.014_bib0405
  article-title: Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2014.06.007
– volume: 187
  start-page: 429
  year: 2012
  ident: 10.1016/j.eururo.2016.07.014_bib0315
  article-title: Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma
  publication-title: J Urol
  doi: 10.1016/j.juro.2011.09.150
– volume: 81
  start-page: 972
  year: 2013
  ident: 10.1016/j.eururo.2016.07.014_bib0290
  article-title: Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma
  publication-title: Urology
  doi: 10.1016/j.urology.2012.12.059
– volume: 33
  start-page: 268.e1
  year: 2015
  ident: 10.1016/j.eururo.2016.07.014_bib0395
  article-title: Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma
  publication-title: Urol Oncol
  doi: 10.1016/j.urolonc.2015.03.006
– volume: 100
  start-page: 264
  year: 2007
  ident: 10.1016/j.eururo.2016.07.014_bib0345
  article-title: Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised?
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2007.06993.x
– volume: 339
  start-page: b2535
  year: 2009
  ident: 10.1016/j.eururo.2016.07.014_bib0245
  article-title: PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
  publication-title: BMJ
  doi: 10.1136/bmj.b2535
– volume: 12
  start-page: 155
  year: 2015
  ident: 10.1016/j.eururo.2016.07.014_bib0225
  article-title: Risk-adapted strategy for the kidney-sparing management of upper tract tumours
  publication-title: Nat Rev Urol
  doi: 10.1038/nrurol.2015.24
– volume: 102
  start-page: 172
  year: 2008
  ident: 10.1016/j.eururo.2016.07.014_bib0340
  article-title: Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2008.07535.x
– volume: 195
  start-page: 1354
  year: 2016
  ident: 10.1016/j.eururo.2016.07.014_bib0365
  article-title: Oncologic outcomes of kidney-sparing surgery versus kidney sparing surgery for the elective treatment of clinically organ confined upper tract urothelial carcinoma of the distal ureter
  publication-title: J Urol
  doi: 10.1016/j.juro.2015.11.036
– reference: 28505892 - J Urol. 2017 Jun;197(6):1437-1438. doi: 10.1016/j.juro.2017.03.046.
– reference: 27687822 - Eur Urol. 2017 Apr;71(4):e109-e110. doi: 10.1016/j.eururo.2016.09.028.
– reference: 27666997 - Eur Urol. 2017 Apr;71(4):e111-e112. doi: 10.1016/j.eururo.2016.09.027.
SSID ssj0003593
Score 2.6122634
SecondaryResourceType review_article
Snippet There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract...
Abstract Context There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1052
SubjectTerms Carcinoma, Transitional Cell - surgery
Humans
Kidney
Kidney Neoplasms - surgery
Nephroureterectomy - methods
Organ Sparing Treatments
Recurrence
Renal pelvis
Survival
Ureter
Ureter - surgery
Ureteral neoplasms
Ureteral Neoplasms - surgery
Ureteroscopy
Ureteroscopy - methods
Urinary tract
Urology
Urothelial carcinoma
Title Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0302283816304195
https://www.clinicalkey.es/playcontent/1-s2.0-S0302283816304195
https://dx.doi.org/10.1016/j.eururo.2016.07.014
https://www.ncbi.nlm.nih.gov/pubmed/27477528
https://www.proquest.com/docview/1826740006
Volume 70
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELa2TkK8IH5TfkyHxGtoUttNwlupNjqmdYgu0t4sx7FRUZtUSYPUF_49_i3umqQCwTSElJdGcZ3kLp8_23ffMfbGRBmy6Fh6QnDriZGMvdjnmRc7p3noD43QtN5xMRtNE_HxWl4fsEmXC0NhlS32N5i-Q-v2zKB9m4P1YjGYo3uSdkuEjMIXQSwP2dEQR_uox47GZ-fT2R6Qeau9y3eZyDzqMuh2YV62LuuSsgCDRsUzEDeNUDcx0N1IdHqf3WspJIybu3zADmz-kN25aDfJH7Efl7lpIA0u6w0-mK2gcHC-yHK79SoqO5h_gXmTDw20YFZX8FnvNmxgZtdUuaekKBla0F9tAWktJOu1LeGKUqogKSlra4mOCxOqRJQXK_0OxjDfi0JDs-MA6RbwSjgZJzArcm9VV3jDcJZ_0xQ0D--XBHsl_gu-9RI-1CS5RWH48EnndvmYJacnV5Op19Zr8Izko40nQz8bWhkZEgCKuHMmcEgHw8AFWjodpBnOL3nmcCKMHuI7JIuZMHYU4ZTU4MGfsF5e5PYZAycNz9I00HGqhUN3kllqBIn_hXHsQt1nvLORMq2YOdXUWKouau2raiyryLLKDxVats-8fat1I-Zxy_WyM7_qElURWhWONre0C__WzlYtPlQqUNVQ-eoPH_615W-fwT_0-brzT4UIQds-aKqixr5wBhkK4iV99rRx3P3T05pEKIfR8__u9wW7S7-aCJ-XrLcpa_sKedomPWaHb78Hx-3X-BPL4j_e
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELWWrgRcEN-Uz0HiGjWp7SbhVqpdWrrtItpKe7Mcx0ZFbVolDVJ_IX-LmSapQLBahJRTE9dJZvL8bM-8YeydiVJk0bH0hODWEz0Ze7HPUy92TvPQ7xqhab1jMu0NF-LTlbw6YYMmF4bCKmvsrzD9gNb1L536bXa2y2Vnhu5J2i0RMgpfBLG8xU4FFbVusdP-aDycHgGZ19q7_JCJzKMmg-4Q5mXLvMwpCzCoVDwDcd0IdR0DPYxE5_fZvZpCQr-6ywfsxGYP2e1JvUn-iP24zEwFaXBZ7vDBbAEbB-Nlmtm9V1DZwewrzKp8aKAFs7KAL_qwYQNTu6XKPTlFydCC_noPSGthsd3aHOaUUgWLnLK2Vui4MKBKRNlmrd9DH2ZHUWiodhwg2QNeCWf9BUw3mbcuC7xhGGXfNQXNw4cVwV6O_4JvPYePJUluURg-fNaZXT1mi_Oz-WDo1fUaPCN5b-fJ0E-7VkaGBIAi7pwJHNLBMHCBlk4HSYrzS546nAijh_gOyWIqjO1FOCU1ePAnrJVtMvuMgZOGp0kS6DjRwqE7yTQxgsT_wjh2oW4z3thImVrMnGpqrFQTtfZNVZZVZFnlhwot22besdW2EvO44XrZmF81iaoIrQpHmxvahX9rZ4saHwoVqKKrfPWHD__a8rfP4B_6fNv4p0KEoG0fNNWmxL5wBhkK4iVt9rRy3OPT05pEKLvR8__u9w27M5xPLtTFaDp-we7SmSra5yVr7fLSvkLOtkte19_kT06AQcQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oncologic+Outcomes+of+Kidney-sparing+Surgery+Versus+Radical+Nephroureterectomy+for+Upper+Tract+Urothelial+Carcinoma%3A+A+Systematic+Review+by+the+EAU+Non-muscle+Invasive+Bladder+Cancer+Guidelines+Panel&rft.jtitle=European+urology&rft.au=Seisen%2C+Thomas&rft.au=Peyronnet%2C+Benoit&rft.au=Dominguez-Escrig%2C+Jose+Luis&rft.au=Bruins%2C+Harman+M.&rft.date=2016-12-01&rft.pub=Elsevier+B.V&rft.issn=0302-2838&rft.volume=70&rft.issue=6&rft.spage=1052&rft.epage=1068&rft_id=info:doi/10.1016%2Fj.eururo.2016.07.014&rft.externalDocID=S0302283816304195
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03022838%2FS0302283816X00103%2Fcov150h.gif